Filter By

download

Webinar Presentation

A Webinar Presentation : How To Better Plan A Virtual Trial

Get the webinar presentation to see lessons learned and recommendations for designing protocols that enable flexibility in your virtual trials' ...

download

Webinar Video Replay

A Webinar Replay | How To Better Plan a Virtual Clinical Trial

Watch the webinar on-demand for lessons learned and recommendations when designing protocols that enable flexibility in your virtual trials' conduct.

download

Infographic

FDA Meeting Types

View our FDA Meeting Types Infographic to learn about Type A, Type B and Type C meetings – with specific insights into meeting timing, purposes and examples of each ...

download

Case Study

Writing Multiple Marketing Applications At The Same Time

A mid-size pharmaceutical company and its development partner, a small biotechnology company engaged Veristat to complete the medical writing for their product’s ...

download

Infographic

The Time for Virtual Clinical Trials is Now

Download the infographic to learn how virtual trials are defined, the tool kits required to run a virtual trial, examples of what the patient experience can look ...

download

Conference Presentation

Gene Therapy: Creative Solutions for Complex Clinical Development Pathways

View the conference presentation to learn about implementing central site models, virtual trials, and novel clinical trial designs to benefit patients and sponsors ...

download

Infographic

The Benefits of a Central Site Model

A centralized site model allows patients to be treated at one or two central sites, which minimizes the travel burden on patients and caregivers. A combination of ...

download

Fact Sheet

Regulatory Consulting Fact Sheet

Regulatory planning for your clinical development program starts before and continues after you begin preparing your Investigational New Drug (IND) application. As ...

download

Case Study

Medical Writing Partnership - IND to NDA

Learn how the Veristat medical writing team partnered with a sponsor and supported their entire rare oncology program from IND to NDA.